Business Wire (November 17, 2008)
Permanent Link:
http://vlex.com/vid/alkermes-molecule-opioid-analgesics-57025243
Id. vLex: VLEX-57025243
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Alkermes Presents Positive Preclinical Data on Novel, Proprietary Molecule Designed to Improve Outcomes for Patients Taking Opioid Analgesics.
Second New Program Disclosed During Calendar 2008
CAMBRIDGE, Mass. -- Alkermes, Inc. (NASDAQ: ALKS) today announced positive preclinical results for its proprietary small molecule candidate, RDC-1036, which emer...Try vLex for FREE for 3 days
Access legal information from United States including:
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here